immunotherapy world

Latest Interviews

Loading
  • Interview with Dr Aron Thall

    12-Jan-2017 by: Phacilitate
    Read our wide ranging interview now to hear what Pfizer are focusing on in the cancer immunotherapy space and how drug developers will start to differentiate themselves, his views on combination therapies and more.
  • Niels Emmerich, Ph.D. Senior Director, Head Search and Evaluation Oncology, Abbvie has been talking to Phacilitate ahead of his talk at Immunotherapy World in under two weeks.

     
  • Hot on the heels of Kite Pharma’s announcement of strong remission results from two KTE-C19 Phase one trials at ASH, what better insight could you ask for than an in-depth, exclusive interview with Dr David D. Chang, Kite’s Executive Vice President R&D and Chief Medical Officer.

    Hear the latest on KTE-C19, how Dr Chang believes we can design clinical trials that recognise the success of new advanced therapies in the clinic, and the challenges associated with establishing an infrastructure and supply chain to enable the commercialization of these therapies.

  • Interview with Dr Niranjan Sardesai

    01-Dec-2016 by: Phacilitate
    Dr Niranjan Sardesai, Chief Operating Officer, Inovio Pharmaceuticals, Inc The concept of your DNA-based immunotherapies, then, is to take the genetic code of cancer antigens, facilitate significant p ...
  • Computational Medicine in the Immuno-Oncology Age

    17-Nov-2016 by: William Loging
    The human body has established immunological processes to keep cancerous cell growth in check. In the late 1990’s, researchers began to identify mechanisms by which tumor cells could evade a patient’s immune system through selective gain-of-function gene mutations(1).
  • The recent front page article in the New York Times is just one recent example of how much media focus is on immuno-oncology; read our interview and find out what VEL Vaccines Biosciences think the major challenges are for researchers to continue to back-up the hype and many more.
  • As part of Phacilitate’s on-going commitment to providing you with fresh insights and exclusives from key opinion leaders from across the immunotherapy space, I am delighted to announce this week’s interview is with Steven King, President & CEO of Peregrine Pharmaceuticals. The big news of 2015 was Peregrine’s clinical collaboration with AstraZeneca to advance Bavituximab

    Having been involved with Peregrine from the 1990s, Steven shares with us how he has seen the immunotherapy field change in that time period, explores whether the immunotherapy field is in a bubble, and offers advice for biotechs looking to establish partnerships with Big Pharma.

  • Life Science Partners have invested over €1BN into biotechs! Now find out from Venture Partner, Dr Vincent Brichard the reasons they led financing into mRNA technology, which therapeutic areas and indications they are currently actively looking to invest in, and what excites and worries him about the immunotherapy sector.
  • Investment and routes to funding has always been a top priority for the life science sector, however post-Brexit and with the increasing uncertainty in the global markets, it is becoming more and more important.

    To address these concerns, along with offering advice to biotechs pitching VCs, and looking at the current risks and values in cell, gene and immunotherapy Phacilitate has been talking exclusively with Joshua Resnick, Partner, SV Life Sciences.

  • Dr Art Krieg, CEO, Checkmate Pharmaceuticals has been talking exclusively with Phacilitate ahead of his appearance at the event.

20 Results

Featured Speakers


 

It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer.

Lance Leopold MD, Vice President, Head of Oncology Development, Incyte Corporation

Attending pharma/biotech companies include

  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • adaptimm
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • aldevron
  • allele
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • apogenix
  • arthrogen
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • g con
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • genvec
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Incyte
  • Attending Pharma/Biotech companies Cell & Gene Therapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • Miami Attending companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • Miami Attending companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • takara
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • Attending Pharma/Biotech companies Immunotherapy World
  • arending companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • vcls
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • Attending Pharma/Biotech companies Immunotherapy World
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • attending pharma/biotech companies
  • world care
  • attending pharma/biotech companies
  • attending pharma/biotech companies